Patients with diabetes seen by a CPS within the PCMH model were very satisfied with the care they received overall.
Diabetic women have higher morbidity and mortality associated with ischemic coronary events than diabetic men, but the extension of coronary artery disease in both groups is less well established.Aim: to compare the extension, magnitude and severity of coronary atherosclerosis between men and women with type 2 diabetes mellitus.Method: 162 consecutive diabetic patients with suspected coronary atherosclerosis studied by coronary angiography were included. The magnitude of atherosclerosis was quantified using the Gensini Score. Results:The average age was 64.8 years. Ninetyfour patients were women (58.0%). Diabetes was present for 152 ± 90.0 months for women and 120 ± 99.4 months for men (p <0.05). Women had a higher body mass index (30.5 ± 5.1) than men (28.5 ± 5.2, p<0.05).The presence of significant coronary atherosclerosis in the entire diabetic population was of 61.7%: 76.5% in men and 51.5% in women (OR 1.5). The mean number of atherosclerotic plaques was 195 in 68 men (2.86 plaques/patient) and 168 in 94 women (1.78 plaques/patient, p=0.0043). Significant atherosclerosis in 1, 2 and 3 vessels was observed in 7.4%, 17.6% and 51.5% of men, respectively, versus 12.8%, 10.6% and 27.7% in women (p<0.0002). The magnitude of coronary disease measured by Gensini Score was 69.4 + 66.7 in men versus 35.6 ± 47.3 in women (p<0.005). Conclusion:Men with diabetes have greater extension, magnitude and severity of coronary atherosclerosis than diabetic women.
number of questions remain. We hypothesized that CRRT may precipitate a form of thrombocytopenia. In trials thrombocytopenia occurred at rates as high as 70%. The etiology remains unknown and results in additional diagnostic workup, and possibly drug therapy. The extent, duration, and temporal relation of thrombocytopenia remains to be determined. Methods: A retrospective study was conducted in patients receiving CRRT for > 24 hrs with no pre-existing diagnosis or cause of thrombocytopenia. Patients were evaluated to determine the influence of CRRT on platelet counts. Patients initiated on CRRT had daily platelet counts monitored, and CRRT attributes and therapeutic interventions where collected. Platelets were assessed for time to nadir, degree of decline, and time to return to baseline after discontinuation of CRRT. Results: A total of 49 patients met inclusion criteria with a male predominance and average age of 60.Most patients required CRRT for acute kidney injury. There was a mean decline in platelets of 48% with a mean of 4.6 days to the nadir. An average 2.5 days was observed until counts rose back to baseline or >150 K. This drop resulted in 37% of patients being tested for heparin induced thrombocytopenia (HIT), of which 0% had a positive test; in 44% of these patients suspicion was high enough to justify initiating therapy. Statistical analysis failed to identify any patient attributes correlated with the probability of thrombocytopenia. Conclusions: CRRT appears to be associated with a precipitous drop in platelet counts within the first 5 days of therapy with an average decline of 48%. However, platelets appear to return to > 150K (or baseline) after cessation of CRRT. This fluctuation should be considered in the setting of patients developing thrombocytopenia after initiated on CRRT.Learning Objectives: Epidemiological estimates suggest that the incidence of leukemias has steadily increased in children. Although, the current 5-year overall survival rate for ALL, the most common type of childhood leukemia, is estimated to be greater than 85%, the need for cardiopulmonary resuscitation(CPR) is associated with increased morbidity and mortality. Current national prevalence estimates and associated outcomes of CPR in children hospitalized with leukemia are unknown. We conducted this tudy to estimate the prevalence of CPR in children hospitalized due to leukemias and to examine the risk factors associated with having a CPR. Methods: We performed a retrospective analysis of the Nationwide Inpatient Sample, the largest all payer in-patient discharge dataset in United States, for the years 2004 to 2010. All patients (age up to 17 years) hospitalized primarily due to any of the leukemias (using ICD 9 CM codes) were selected. Performance of CPR in this cohort was examined. The simultaneous association of multiple patient level factors on odds of having a CPR was examined by multivariable logistic regression model. Results: A total of 48,945 children were hospitalized primarily due to leukemias. This cohort inc...
Renal angioplasty with stent using CO 2 as contrast medium. Report of one caseRevascularization procedures for atherosclerotic renovascular hypertension are aimed to improve or cure hypertension and to reduce the progression to ischemic nephropathy and renal failure. Renal angioplasty is the preferred method, but a common complication is contrast-induced nephropathy. To avoid or lessen this complication, CO 2 can be used as a contrast medium. We report a 68 year-old woman with renovascular hypertension and mild deterioration of renal function in whom we implanted an stent using digital substraction angiography and CO 2 as contrast medium, which was injected manually. We obtained satisfactory images and we ended the procedure without complications. Blood pressure fell and creatinine levels did not change (Rev Méd Chile 2007; 135: 365-69). (
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.